From the Department of Pediatrics, Division of Rheumatology, and the Department of Medical Genetics, Hacettepe University Faculty of Medicine, Ankara; Department of Bioinformatics, Institute of Health Sciences, Hacettepe University, Ankara; Department of Pediatrics, Division of Rheumatology, Istanbul University Cerrahpasa Faculty of Medicine, Istanbul; Department of Pediatrics, Division of Nephrology and Rheumatology, Akdeniz University Faculty of Medicine, Antalya; Department of Pediatrics, Division of Rheumatology, Umraniye Training and Research Center, University of Health Sciences, Istanbul; Department of Pediatrics, Division of Rheumatology, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey.
E.D. Batu, MD, MSc, Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine; C. Koşukcu, MSc, Department of Medical Genetics, Hacettepe University Faculty of Medicine, and Department of Bioinformatics, Institute of Health Sciences, Hacettepe University; E. Taşkıran, PhD, Department of Medical Genetics, Hacettepe University Faculty of Medicine; S. Sahin, MD, Department of Pediatrics, Division of Rheumatology, Istanbul University Cerrahpasa Faculty of Medicine; S. Akman, MD, Department of Pediatrics, Division of Nephrology and Rheumatology, Akdeniz University Faculty of Medicine; B. Sözeri, MD, Department of Pediatrics, Division of Rheumatology, Umraniye Training and Research Center, University of Health Sciences; E. Ünsal, MD, Department of Pediatrics, Division of Rheumatology, Dokuz Eylül University Faculty of Medicine; Y. Bilginer, MD, MSc, Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine; O. Kasapcopur, MD, Department of Pediatrics, Division of Rheumatology, Istanbul University Cerrahpasa Faculty of Medicine; M. Alikaşifoğlu, MD, PhD, Department of Medical Genetics, Hacettepe University Faculty of Medicine; S. Ozen, MD, MSc, Department of Pediatrics, Division of Rheumatology, Hacettepe University Faculty of Medicine.
J Rheumatol. 2018 Dec;45(12):1671-1679. doi: 10.3899/jrheum.171358. Epub 2018 Jul 15.
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disorder. Early-onset, familial, and/or syndromic SLE may reveal monogenic pathologies. The aim of this study was to examine genetic associations in patients with early-onset or familial SLE.
We enrolled 7 SLE cases (from different families) with disease onset ≤ 5 years of age and family history consistent with an autosomal recessive inheritance. Whole exome sequencing (WES) was performed in 6 index cases. Suspected variants were confirmed by Sanger sequencing. We did not perform WES in 1 patient who had features similar to the first 3 cases; only the exons of and were screened with Sanger sequencing.
We demonstrated 2 novel and 3 previously reported variants in genes associated with SLE: a homozygous non-sense alteration (c.622C>T/p.Gln208Ter) in in 2 patients; homozygous non-sense alteration (c.79C>T/p.Gln27Ter) in in 1 (novel variant); homozygous missense alteration (c.100G>A/p.Gly34Arg) in in 1; homozygous missense alteration (c.1945G>C/p.Ala649Pro) in in 1 (novel variant); and homozygous frameshift alteration (c.289_290delAC/p.Thr97Ilefs*2) in in 1 patient. Further, in 1 patient, we determined a strong candidate variant in (histone decetylase 7).
Five patients had homozygous alterations in genes coding early complement proteins. This may lead to decreased clearance of apoptotic bodies. One patient had variant, which functions in the clearance of self-antigens. In 1 patient, we determined a novel gene that may be important in SLE pathogenesis. We suggest that monogenic causes/associations should be sought in early-onset and/or familial SLE.
系统性红斑狼疮(SLE)是一种多系统自身免疫性疾病。早发型、家族性和/或综合征性 SLE 可能揭示单基因病理学。本研究旨在研究早发型或家族性 SLE 患者的遗传相关性。
我们招募了 7 名(来自不同家庭)疾病发病年龄≤ 5 岁且家族史符合常染色体隐性遗传的 SLE 患者。对 6 名指数患者进行了全外显子组测序(WES)。通过 Sanger 测序证实可疑变异。我们没有对具有与前 3 例相似特征的 1 名患者进行 WES 检测;仅对 和 基因的外显子进行了 Sanger 测序。
我们在与 SLE 相关的基因中发现了 2 个新的和 3 个先前报道的变异:2 名患者中 基因的纯合无义改变(c.622C>T/p.Gln208Ter);1 名患者中 基因的纯合无义改变(c.79C>T/p.Gln27Ter)(新变异);1 名患者中 基因的纯合错义改变(c.100G>A/p.Gly34Arg);1 名患者中 基因的纯合错义改变(c.1945G>C/p.Ala649Pro)(新变异);和 1 名患者中 基因的纯合移码改变(c.289_290delAC/p.Thr97Ilefs*2)。此外,在 1 名患者中,我们确定了 基因中一个强有力的候选变异(组蛋白脱乙酰酶 7)。
五名患者的早期补体蛋白编码基因存在纯合改变。这可能导致凋亡小体的清除减少。一名患者携带 变异,该变异在清除自身抗原方面起作用。在 1 名患者中,我们确定了一个可能对 SLE 发病机制很重要的新基因。我们建议在早发型和/或家族性 SLE 中寻找单基因病因/关联。